FDA Adverse Event Other Summary report: N

SMART MONITOR 2

MDR report key: 2093982 · Received April 27, 2011

Report

Report Number
3007056120-2011-00011
Event Type
Other
Date Received
April 27, 2011
Date of Event
March 25, 2011
Report Date
March 31, 2011
Manufacturer
PHILIPS RESPIRONICS, INC.
Product Code
FLS
PMA / PMN Number
K011597
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE SMARTMONITOR 2 WAS SET UP WITH A 20 SECOND DELAY BEFORE RECORDING APNEAS AND A 20 SECOND DELAY BEFORE ANNUNCIATING AND RECORDING AN ALARM FOR AN APNEA CONDITION. THE SMARTMONITOR 2 WAS PROGRAMMED WITH PARAMETERS THAT WERE APPROPRIATE FOR RECORDING AND ALARMING FOR RESPIRATION AND HEART RATE EVENTS DURING INFANT MONITORING. THE APNEA MONITOR'S MEMORY DATA WAS DOWNLOADED AND ANALYZED BY TRAINED ASSOCIATES. THE DOWNLOADED MEMORY REVEALED THE APNEA MONITOR WAS IN USE FROM (B)(6) 2011. DURING THAT TIME THERE WERE 87 RECORDED PATIENT EVENTS. THERE WAS NO PATIENT EVENT RECORDED AT THE TIME OF THE ALLEGED EVENT; HOWEVER, ALL RECORDED PATIENT EVENTS WERE ASSOCIATED WITH AUDIBLE AND VISUAL ALARMS. THE SMARTMONITOR 2 DEVICE IS NOT INTENDED TO BE USED TO MONITOR PATIENTS FOR CYANOSIS AND HAS NO CAPABILITY TO DO SO. THE SMARTMONITOR 2 PARENTS' GUIDE ((B)(4)) STATES IN THE INDICATIONS FOR USE: "THE SMARTMONITOR 2 IS INTENDED FOR USE IN CONTINUOUS MONITORING OF HEART RATE AND RESPIRATION OF INFANT PATIENTS IN A HOME, HOSPITAL OR PORTABLE ENVIRONMENT. ITS PRIMARY FUNCTION IS DETECTION OF CENTRAL APNEA. ITS SECONDARY FUNCTION IS MEASUREMENT OF HEART RATE." THE SMARTMONITOR 2 DEVICE IS NOT INTENDED TO PREVENT LOSS OF BREATHING OR HEART ACTIVITY. THE SMARTMONITOR 2 PARENTS' GUIDE ((B)(4)) FURTHER STATES: "THE SMART MONITOR 2 IS A MONITORING DEVICE ONLY. IT DOES NOT PREVENT THE LOSS OF BREATHING OR HEART ACTIVITY, NOR WILL IT RESTORE BREATHING OR HEART ACTIVITY. IT WILL NOT PREVENT DEATH. ANYONE USING THE SMARTMONITOR 2 TO MONITOR AN INFANT SHOULD BE TRAINED IN CURRENT INFANT CARDIOPULMONARY RESUSCITATION (CPR) WHICH IS A PROPER WAY TO RESTORE BREATHING AND HEART ACTIVITY." THERE WAS NO REPORT OF DEATH OR SERIOUS INJURY, AND THE MANUFACTURER WAS NOT ABLE TO CONFIRM THE ALLEGATION OF ALARM FAILURE DURING A PATIENT EVENT. THE MONITOR PASSED ALL REQUIRED TESTING AND DETECTED AND ALARMED APPROPRIATELY FOR SIMULATED EVENTS. BASED ON ALL AVAILABLE INFORMATION, THE MANUFACTURER CONCLUDES THAT THE DEVICE DOES FUNCTION TO SPECIFICATION AND THAT NO FURTHER ACTION IS APPROPRIATE.

Description of Event or Problem · 1

A DURABLE MEDICAL EQUIPMENT (DME) SUPPLIER REPORTED AN INFANT APNEA MONITOR DID NOT ALARM DURING AN APNEIC AND CYANOTIC PATIENT EVENT ON (B)(6) 2011 AT 8:30 PM. IT WAS REPORTED THAT THE CAREGIVER OF THE INFANT PERFORMED CARDIOPULMONARY RESUSCITATION (CPR) AND THE INFANT WAS SUBSEQUENTLY TAKEN TO THE HOSPITAL FOR OBSERVATION. NO DEATH OR SERIOUS INJURY RESULTED. THE MANUFACTURER RECEIVED THE DEVICE FOR EVALUATION AND DID NOT CONFIRM THE CUSTOMER'S COMPLAINT OF THE UNIT NOT ALARMING. THE APNEA MONITOR WAS VISUALLY EXAMINED AND TESTED BY THE MANUFACTURER USING A SIMULATOR IN ACCORDANCE WITH THE SMARTMONITOR 2 CHECKOUT PROCEDURE MANUAL ((B)(4)). THE APNEA MONITOR DETECTED AND ALARMED APPROPRIATELY FOR SIMULATED EVENTS AND PASSED ALL REQUIRED TESTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SMART MONITOR 2 APNEA MONITOR FLS PHILIPS RESPIRONICS, INC. 4002

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization